Domenico Ribatti
University of Bari
965 Papers
6.1K Citations
Domenico Ribatti is an academic researcher from University of Bari. The author has contributed to research in topics: Angiogenesis & Biology. The author has an hindex of 96, co-authored 913 publications. Previous affiliations of Domenico Ribatti include University of Genoa & National Institutes of Health.
Chat about Author
Papers
The bursa of Hieronymus Fabricius ab Aquapendente: from original iconography to most recent research.
TL;DR: The bursa of Fabricius is universally known as the origin of B-lymphocytes; morphogenetical and physiological issues are also considered in this paper, along with corrections of some mislabeling still presents in some anastatic copies.
Chapter 8 – The Zebrafish
Domenico Ribatti
- 01 Jan 2018
TL;DR: Zebrafish will represent an important tool for chemical discovery and gene targeting in tumor angiogenesis and high-resolution in vivo imaging techniques are also becoming available in zebrafish.
2
Sales for anti-angiogenic drugs.
TL;DR: Despite antiangiogenic therapy has increased PFS of patients with cancer, the pooled results showed that overall survival improvement was very limited, and it is also important to reach a general consensus as concerns the treatment timeline when anti-ANGiogenic drugs are used.
Chapter 2 – The Corneal Assay for Angiogenesis
Domenico Ribatti
- 01 Jan 2018
TL;DR: This assay is carried out by first creating a pocket in the cornea where the compound of interest is inserted and monitoring the progress of vessel formation, the absence of existing background vasculature, and adaptation for use in mice.
2
Glycated-FGF-2 is quickly produced in vitro upon low-millimolar glucose treatment and detected in vivo in diabetic mice.
Francesco Facchiano,Katia Russo,Vincenzo Fogliano,Carmela Mennella,Raffaele Ragone,Giovanna Zambruno,Virginia Carbone,Domenico Ribatti,Cesare Peschle,Maurizio C. Capogrossi,Antonio Facchiano,Medicina Molecolare +11 more
- 01 Jan 2006
TL;DR: Biochemical analyses carried out with SDS-PAGE, fluorescence emission, mass-spectrometry, immunoblot and competitive ELISA experiments demonstrated that human FGF-2 undergoes a rapid and specific glycation upon 12.5-50 mM glucose exposure.
2